Holger Keim

This inventor holds 62 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Autoimmune Therapies (CPC class C07D). Top assignees: Rigel Pharmaceuticals, Incorporated, Dade Behring Inc., Rogel Pharmaceuticals, Inc.. Active years: 2006-2023.

USPTO Granted Patents = 62 (Patent Applications = 3)

% Patents Active = 59.7

CIPO Patents = 4

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 9.8

ph-index = 31

Forward Citations = 2,821(Granted Patents)

Forward Citations (Not Self Cited) = 2,260(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Wycoff, NJ (US) (2010)
Wyckoff, NJ (US) (2007 - 2013)
Menlo Park, CA (US) (2006 - 2017)
Irvine, CA (US) (2010 - 2022)
Newbury Park, CA (US) (2016 - 2023)

Company Filing History:

60 out of 492

Rigel Pharmaceuticals, Incorporated

Rogel Pharmaceuticals, Inc.

patent

Years Active: 2006-2023

Loading Chart...

Areas of Expertise:

JAK Pathway

2,4-Pyrimidinediamine

Autoimmune Diseases

Therapeutic Compositions

Disease Prevention

Pharmaceutical Methods

Inhibition Techniques

Compound Uses

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11827628 - Compositions and methods for inhibition of the JAK pathway (2023-11-28),

2. 11230554 - Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds (2022-01-25),

3. 11198689 - Compositions and methods for inhibition of the JAK pathway (2021-12-14),

4. 11007193 - 2,4-pyrimidinediamine compounds and their uses (2021-05-18),

5. 10828301 - 2,4-pyrimidinediamine compounds and their uses (2020-11-10),

6. 10709703 - 2,4-pyrimidinediamine compounds and their uses (2020-07-14),

7. 10682350 - 2,4-pyrimidinediamine compounds and their uses (2020-06-16),

8. 10421752 - Compositions and methods for inhibition of the JAK pathway (2019-09-24),

9. 10369148 - 2,4-pyrimidinediamine compounds and their uses (2019-08-06),

10. 10314840 - 2,4-pyrimidinediamine compounds and their uses (2019-06-11),

11. 10259826 - Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds (2019-04-16),

12. 9913842 - 2,4-pyrimidinediamine compounds and their uses (2018-03-13),

13. 9751893 - Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds (2017-09-05),

14. 9732073 - Compositions and methods for inhibition of the JAK pathway (2017-08-15),

15. 9586908 - 2,4-pyrimidinediamine compounds and their uses (2017-03-07),

Title: Holger Keim: Pioneering Inventor from Irvine

Introduction: Holger Keim is a renowned inventor based in Irvine, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Holger Keim holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse expertise and innovative mindset.

Career Highlights: With over two decades of experience in the industry, Holger Keim has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized their respective fields.

Collaborations: Throughout his career, Holger Keim has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Holger Keim's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs worldwide.